APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Drug Peptide API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GLP-1 Drug Peptide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025197 pages

Choose your research edition.

Industry ResearchGLP-1 Drug Peptide API Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Drug Peptide API Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal GLP-1 Drug Peptide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Drug Peptide API Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Drug Peptide API Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global GLP-1 Drug Peptide API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for GLP-1 Drug Peptide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GLP-1 Drug Peptide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Drug Peptide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GLP-1 Drug Peptide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GLP-1 Drug Peptide API include CPC Scientific, Novo Nordisk, Teva Pharmaceutical Industries Ltd, HYBIO Pharmaceutical, JYMedtech, SINOPEP, Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical and WuXi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines GLP-1 Drug Peptide API output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of GLP-1 Drug Peptide API by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global GLP-1 Drug Peptide API market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GLP-1 Drug Peptide API and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GLP-1 Drug Peptide API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GLP-1 Drug Peptide API market size, projected growth trends, production technologies, key applications, and end-use industries.

GLP-1 Drug Peptide API Segment by Company

CPC Scientific

Novo Nordisk

Teva Pharmaceutical Industries Ltd

HYBIO Pharmaceutical

JYMedtech

SINOPEP

Shengnuo Biotechnology

Suzhou Tianma Pharmaceutical

WuXi AppTec

Zhejiang Peptites Biotech

GLP-1 Drug Peptide API Segment by Type

Semaglutide

Liraglutide

Tilpotide

GLP-1 Drug Peptide API Segment by Application

Diabetes

Obesity

Other

GLP-1 Drug Peptide API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Drug Peptide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Drug Peptide API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Drug Peptide API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GLP-1 Drug Peptide API market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GLP-1 Drug Peptide API industry.

Chapter 3: Detailed analysis of GLP-1 Drug Peptide API market competition landscape. Including GLP-1 Drug Peptide API manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of GLP-1 Drug Peptide API by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of GLP-1 Drug Peptide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. GLP-1 Drug Peptide API Industry Trends Table 2. GLP-1 Drug Peptide API Industry Drivers Table 3. GLP-1 Drug Peptide API Industry Opportunities and Challenges Table 4. GLP-1 Drug Peptide API Industry Restraints Table 5. Global GLP-1 Drug Peptide API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global GLP-1 Drug Peptide API Production Value Share by Manufacturers (2021-2026) Table 7. Global GLP-1 Drug Peptide API Production by Manufacturers (Tons) & (2021-2026) Table 8. Global GLP-1 Drug Peptide API Production Market Share by Manufacturers Table 9. Global GLP-1 Drug Peptide API Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global GLP-1 Drug Peptide API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global GLP-1 Drug Peptide API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global GLP-1 Drug Peptide API Manufacturers, Product Type & Application Table 13. Global GLP-1 Drug Peptide API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global GLP-1 Drug Peptide API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Semaglutide Table 17. Major Manufacturers of Liraglutide Table 18. Major Manufacturers of Tilpotide Table 19. Global GLP-1 Drug Peptide API Production by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global GLP-1 Drug Peptide API Production by Type (2021-2026) & (Tons) Table 21. Global GLP-1 Drug Peptide API Production by Type (2027-2032) & (Tons) Table 22. Global GLP-1 Drug Peptide API Production Market Share by Type (2021-2026) Table 23. Global GLP-1 Drug Peptide API Production Market Share by Type (2027-2032) Table 24. Global GLP-1 Drug Peptide API Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global GLP-1 Drug Peptide API Production Value by Type (2021-2026) & (Tons) Table 26. Global GLP-1 Drug Peptide API Production Value by Type (2027-2032) & (Tons) Table 27. Global GLP-1 Drug Peptide API Production Value Market Share by Type (2021-2026) Table 28. Global GLP-1 Drug Peptide API Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Diabetes Table 30. Major Manufacturers of Obesity Table 31. Major Manufacturers of Other Table 32. Global GLP-1 Drug Peptide API Production by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global GLP-1 Drug Peptide API Production by Application (2021-2026) & (Tons) Table 34. Global GLP-1 Drug Peptide API Production by Application (2027-2032) & (Tons) Table 35. Global GLP-1 Drug Peptide API Production Market Share by Application (2021-2026) Table 36. Global GLP-1 Drug Peptide API Production Market Share by Application (2027-2032) Table 37. Global GLP-1 Drug Peptide API Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global GLP-1 Drug Peptide API Production Value by Application (2021-2026) & (Tons) Table 39. Global GLP-1 Drug Peptide API Production Value by Application (2027-2032) & (Tons) Table 40. Global GLP-1 Drug Peptide API Production Value Market Share by Application (2021-2026) Table 41. Global GLP-1 Drug Peptide API Production Value Market Share by Application (2027-2032) Table 42. CPC Scientific Company Information Table 43. CPC Scientific Business Overview Table 44. CPC Scientific GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. CPC Scientific GLP-1 Drug Peptide API Product Portfolio Table 46. CPC Scientific Recent Development Table 47. Novo Nordisk Company Information Table 48. Novo Nordisk Business Overview Table 49. Novo Nordisk GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. Novo Nordisk GLP-1 Drug Peptide API Product Portfolio Table 51. Novo Nordisk Recent Development Table 52. Teva Pharmaceutical Industries Ltd Company Information Table 53. Teva Pharmaceutical Industries Ltd Business Overview Table 54. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product Portfolio Table 56. Teva Pharmaceutical Industries Ltd Recent Development Table 57. HYBIO Pharmaceutical Company Information Table 58. HYBIO Pharmaceutical Business Overview Table 59. HYBIO Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. HYBIO Pharmaceutical GLP-1 Drug Peptide API Product Portfolio Table 61. HYBIO Pharmaceutical Recent Development Table 62. JYMedtech Company Information Table 63. JYMedtech Business Overview Table 64. JYMedtech GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. JYMedtech GLP-1 Drug Peptide API Product Portfolio Table 66. JYMedtech Recent Development Table 67. SINOPEP Company Information Table 68. SINOPEP Business Overview Table 69. SINOPEP GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. SINOPEP GLP-1 Drug Peptide API Product Portfolio Table 71. SINOPEP Recent Development Table 72. Shengnuo Biotechnology Company Information Table 73. Shengnuo Biotechnology Business Overview Table 74. Shengnuo Biotechnology GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Shengnuo Biotechnology GLP-1 Drug Peptide API Product Portfolio Table 76. Shengnuo Biotechnology Recent Development Table 77. Suzhou Tianma Pharmaceutical Company Information Table 78. Suzhou Tianma Pharmaceutical Business Overview Table 79. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product Portfolio Table 81. Suzhou Tianma Pharmaceutical Recent Development Table 82. WuXi AppTec Company Information Table 83. WuXi AppTec Business Overview Table 84. WuXi AppTec GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. WuXi AppTec GLP-1 Drug Peptide API Product Portfolio Table 86. WuXi AppTec Recent Development Table 87. Zhejiang Peptites Biotech Company Information Table 88. Zhejiang Peptites Biotech Business Overview Table 89. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product Portfolio Table 91. Zhejiang Peptites Biotech Recent Development Table 92. Global GLP-1 Drug Peptide API Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 93. Global GLP-1 Drug Peptide API Production by Region (2021-2026) & (Tons) Table 94. Global GLP-1 Drug Peptide API Production Market Share by Region (2021-2026) Table 95. Global GLP-1 Drug Peptide API Production Forecast by Region (2027-2032) & (Tons) Table 96. Global GLP-1 Drug Peptide API Production Market Share Forecast by Region (2027-2032) Table 97. Global GLP-1 Drug Peptide API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Global GLP-1 Drug Peptide API Production Value by Region (2021-2026) & (US$ Million) Table 99. Global GLP-1 Drug Peptide API Production Value Share by Region (2021-2026) Table 100. Global GLP-1 Drug Peptide API Production Value by Region (2027-2032) & (US$ Million) Table 101. Global GLP-1 Drug Peptide API Production Value Share by Region: (2027-2032) & (US$ Million) Table 102. Global GLP-1 Drug Peptide API Market Average Price (US$/Ton) by Region (2021-2026) Table 103. Global GLP-1 Drug Peptide API Market Average Price (US$/Ton) by Region (2027-2032) Table 104. Global GLP-1 Drug Peptide API Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 105. Global GLP-1 Drug Peptide API Consumption by Region (2021-2026) & (Tons) Table 106. Global GLP-1 Drug Peptide API Consumption Market Share by Region (2021-2026) Table 107. Global GLP-1 Drug Peptide API Consumption Forecasted by Region (2027-2032) & (Tons) Table 108. Global GLP-1 Drug Peptide API Consumption Forecasted Market Share by Region (2027-2032) Table 109. North America GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 110. North America GLP-1 Drug Peptide API Consumption by Country (2021-2026) & (Tons) Table 111. North America GLP-1 Drug Peptide API Consumption by Country (2027-2032) & (Tons) Table 112. Europe GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 113. Europe GLP-1 Drug Peptide API Consumption by Country (2021-2026) & (Tons) Table 114. Europe GLP-1 Drug Peptide API Consumption by Country (2027-2032) & (Tons) Table 115. Asia Pacific GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 116. Asia Pacific GLP-1 Drug Peptide API Consumption by Country (2021-2026) & (Tons) Table 117. Asia Pacific GLP-1 Drug Peptide API Consumption by Country (2027-2032) & (Tons) Table 118. South America GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 119. South America GLP-1 Drug Peptide API Consumption by Country (2021-2026) & (Tons) Table 120. South America GLP-1 Drug Peptide API Consumption by Country (2027-2032) & (Tons) Table 121. Middle East & Africa GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 122. Middle East & Africa GLP-1 Drug Peptide API Consumption by Country (2021-2026) & (Tons) Table 123. Middle East & Africa GLP-1 Drug Peptide API Consumption by Country (2027-2032) & (Tons) Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. GLP-1 Drug Peptide API Distributors List Table 127. GLP-1 Drug Peptide API Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. GLP-1 Drug Peptide API Product Image Figure 2. Global GLP-1 Drug Peptide API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Drug Peptide API Production Value (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Drug Peptide API Production Capacity (2021-2032) & (Tons) Figure 5. Global GLP-1 Drug Peptide API Production (2021-2032) & (Tons) Figure 6. Global GLP-1 Drug Peptide API Average Price (US$/Ton) & (2021-2032) Figure 7. Global Top 5 and 10 GLP-1 Drug Peptide API Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Semaglutide Image Figure 10. Liraglutide Image Figure 11. Tilpotide Image Figure 12. Global GLP-1 Drug Peptide API Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global GLP-1 Drug Peptide API Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global GLP-1 Drug Peptide API Production Market Share by Type (2021-2032) Figure 15. Global GLP-1 Drug Peptide API Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global GLP-1 Drug Peptide API Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global GLP-1 Drug Peptide API Production Value Share by Type (2021-2032) Figure 18. Diabetes Image Figure 19. Obesity Image Figure 20. Other Image Figure 21. Global GLP-1 Drug Peptide API Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global GLP-1 Drug Peptide API Production Market Share 2021 VS 2025 VS 2032 Figure 23. Global GLP-1 Drug Peptide API Production Market Share by Application (2021-2032) Figure 24. Global GLP-1 Drug Peptide API Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global GLP-1 Drug Peptide API Production Value Share 2021 VS 2025 VS 2032 Figure 26. Global GLP-1 Drug Peptide API Production Value Share by Application (2021-2032) Figure 27. Global GLP-1 Drug Peptide API Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global GLP-1 Drug Peptide API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global GLP-1 Drug Peptide API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global GLP-1 Drug Peptide API Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America GLP-1 Drug Peptide API Production Value (2021-2032) & (US$ Million) Figure 32. Europe GLP-1 Drug Peptide API Production Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific GLP-1 Drug Peptide API Production Value (2021-2032) & (US$ Million) Figure 34. South America GLP-1 Drug Peptide API Production Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa GLP-1 Drug Peptide API Production Value (2021-2032) & (US$ Million) Figure 36. North America GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 37. North America GLP-1 Drug Peptide API Consumption Market Share by Country (2021-2032) Figure 38. U.S. GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. Canada GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Mexico GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Europe GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Europe GLP-1 Drug Peptide API Consumption Market Share by Country (2021-2032) Figure 43. Germany GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. France GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. U.K. GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Italy GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Netherlands GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Asia Pacific GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Asia Pacific GLP-1 Drug Peptide API Consumption Market Share by Country (2021-2032) Figure 50. China GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. Japan GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. South Korea GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Southeast Asia GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. India GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Australia GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South America GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America GLP-1 Drug Peptide API Consumption Market Share by Country (2021-2032) Figure 58. Brazil GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Argentina GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Chile GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Colombia GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Middle East & Africa GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Middle East & Africa GLP-1 Drug Peptide API Consumption Market Share by Country (2021-2032) Figure 64. Egypt GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. South Africa GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. Israel GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 67. Türkiye GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 68. GCC Countries GLP-1 Drug Peptide API Consumption and Growth Rate (2021-2032) & (Tons) Figure 69. GLP-1 Drug Peptide API Value Chain Figure 70. Manufacturing Cost Structure Figure 71. GLP-1 Drug Peptide API Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Semaglutide
  • Liraglutide
  • Tilpotide
Applications
  • Diabetes
  • Obesity
  • Other
Companies covered
  • CPC Scientific
  • Novo Nordisk
  • Teva Pharmaceutical Industries Ltd
  • HYBIO Pharmaceutical
  • JYMedtech
  • SINOPEP
  • Shengnuo Biotechnology
  • Suzhou Tianma Pharmaceutical
  • WuXi AppTec
  • Zhejiang Peptites Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP-1 Drug Peptide API Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GLP-1 Drug Peptide API Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global GLP-1 Drug Peptide API Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global GLP-1 Drug Peptide API Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global GLP-1 Drug Peptide API Market Dynamics
  1. 2.1 GLP-1 Drug Peptide API Industry Trends
  2. 2.2 GLP-1 Drug Peptide API Industry Drivers
  3. 2.3 GLP-1 Drug Peptide API Industry Opportunities and Challenges
  4. 2.4 GLP-1 Drug Peptide API Industry Restraints
3 GLP-1 Drug Peptide API Market by Manufacturers
  1. 3.1 Global GLP-1 Drug Peptide API Production Value by Manufacturers (2021-2026)
  2. 3.2 Global GLP-1 Drug Peptide API Production by Manufacturers (2021-2026)
  3. 3.3 Global GLP-1 Drug Peptide API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global GLP-1 Drug Peptide API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GLP-1 Drug Peptide API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global GLP-1 Drug Peptide API Manufacturers, Product Type & Application
  7. 3.7 Global GLP-1 Drug Peptide API Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GLP-1 Drug Peptide API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GLP-1 Drug Peptide API Players Market Share by Production Value in 2025
  11. 3.8.3 2025 GLP-1 Drug Peptide API Tier 1, Tier 2, and Tier 3
4 GLP-1 Drug Peptide API Market by Type
  1. 4.1 GLP-1 Drug Peptide API Type Introduction
  2. 4.1.1 Semaglutide
  3. 4.1.2 Liraglutide
  4. 4.1.3 Tilpotide
  5. 4.2 Global GLP-1 Drug Peptide API Production by Type
  6. 4.2.1 Global GLP-1 Drug Peptide API Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global GLP-1 Drug Peptide API Production by Type (2021-2032)
  8. 4.2.3 Global GLP-1 Drug Peptide API Production Market Share by Type (2021-2032)
  9. 4.3 Global GLP-1 Drug Peptide API Production Value by Type
  10. 4.3.1 Global GLP-1 Drug Peptide API Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global GLP-1 Drug Peptide API Production Value by Type (2021-2032)
  12. 4.3.3 Global GLP-1 Drug Peptide API Production Value Market Share by Type (2021-2032)
5 GLP-1 Drug Peptide API Market by Application
  1. 5.1 GLP-1 Drug Peptide API Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Obesity
  4. 5.1.3 Other
  5. 5.2 Global GLP-1 Drug Peptide API Production by Application
  6. 5.2.1 Global GLP-1 Drug Peptide API Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GLP-1 Drug Peptide API Production by Application (2021-2032)
  8. 5.2.3 Global GLP-1 Drug Peptide API Production Market Share by Application (2021-2032)
  9. 5.3 Global GLP-1 Drug Peptide API Production Value by Application
  10. 5.3.1 Global GLP-1 Drug Peptide API Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global GLP-1 Drug Peptide API Production Value by Application (2021-2032)
  12. 5.3.3 Global GLP-1 Drug Peptide API Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 CPC Scientific
  2. 6.1.1 CPC Scientific Company Information
  3. 6.1.2 CPC Scientific Business Overview
  4. 6.1.3 CPC Scientific GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 CPC Scientific GLP-1 Drug Peptide API Product Portfolio
  6. 6.1.5 CPC Scientific Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk GLP-1 Drug Peptide API Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Teva Pharmaceutical Industries Ltd
  14. 6.3.1 Teva Pharmaceutical Industries Ltd Company Information
  15. 6.3.2 Teva Pharmaceutical Industries Ltd Business Overview
  16. 6.3.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product Portfolio
  18. 6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
  19. 6.4 HYBIO Pharmaceutical
  20. 6.4.1 HYBIO Pharmaceutical Company Information
  21. 6.4.2 HYBIO Pharmaceutical Business Overview
  22. 6.4.3 HYBIO Pharmaceutical GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 HYBIO Pharmaceutical GLP-1 Drug Peptide API Product Portfolio
  24. 6.4.5 HYBIO Pharmaceutical Recent Developments
  25. 6.5 JYMedtech
  26. 6.5.1 JYMedtech Company Information
  27. 6.5.2 JYMedtech Business Overview
  28. 6.5.3 JYMedtech GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 JYMedtech GLP-1 Drug Peptide API Product Portfolio
  30. 6.5.5 JYMedtech Recent Developments
  31. 6.6 SINOPEP
  32. 6.6.1 SINOPEP Company Information
  33. 6.6.2 SINOPEP Business Overview
  34. 6.6.3 SINOPEP GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 SINOPEP GLP-1 Drug Peptide API Product Portfolio
  36. 6.6.5 SINOPEP Recent Developments
  37. 6.7 Shengnuo Biotechnology
  38. 6.7.1 Shengnuo Biotechnology Company Information
  39. 6.7.2 Shengnuo Biotechnology Business Overview
  40. 6.7.3 Shengnuo Biotechnology GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Shengnuo Biotechnology GLP-1 Drug Peptide API Product Portfolio
  42. 6.7.5 Shengnuo Biotechnology Recent Developments
  43. 6.8 Suzhou Tianma Pharmaceutical
  44. 6.8.1 Suzhou Tianma Pharmaceutical Company Information
  45. 6.8.2 Suzhou Tianma Pharmaceutical Business Overview
  46. 6.8.3 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product Portfolio
  48. 6.8.5 Suzhou Tianma Pharmaceutical Recent Developments
  49. 6.9 WuXi AppTec
  50. 6.9.1 WuXi AppTec Company Information
  51. 6.9.2 WuXi AppTec Business Overview
  52. 6.9.3 WuXi AppTec GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 WuXi AppTec GLP-1 Drug Peptide API Product Portfolio
  54. 6.9.5 WuXi AppTec Recent Developments
  55. 6.10 Zhejiang Peptites Biotech
  56. 6.10.1 Zhejiang Peptites Biotech Company Information
  57. 6.10.2 Zhejiang Peptites Biotech Business Overview
  58. 6.10.3 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product Portfolio
  60. 6.10.5 Zhejiang Peptites Biotech Recent Developments
7 Global GLP-1 Drug Peptide API Production by Region
  1. 7.1 Global GLP-1 Drug Peptide API Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global GLP-1 Drug Peptide API Production by Region (2021-2032)
  3. 7.2.1 Global GLP-1 Drug Peptide API Production by Region (2021-2026)
  4. 7.2.2 Global GLP-1 Drug Peptide API Production Forecast by Region (2027-2032)
  5. 7.3 Global GLP-1 Drug Peptide API Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global GLP-1 Drug Peptide API Production Value by Region (2021-2032)
  7. 7.4.1 Global GLP-1 Drug Peptide API Production Value by Region (2021-2026)
  8. 7.4.2 Global GLP-1 Drug Peptide API Production Value by Region (2027-2032)
  9. 7.5 Global GLP-1 Drug Peptide API Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America GLP-1 Drug Peptide API Production Value (2021-2032)
  12. 7.6.2 Europe GLP-1 Drug Peptide API Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific GLP-1 Drug Peptide API Production Value (2021-2032)
  14. 7.6.4 South America GLP-1 Drug Peptide API Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa GLP-1 Drug Peptide API Production Value (2021-2032)
8 Global GLP-1 Drug Peptide API Consumption by Region
  1. 8.1 Global GLP-1 Drug Peptide API Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global GLP-1 Drug Peptide API Consumption by Region (2021-2032)
  3. 8.2.1 Global GLP-1 Drug Peptide API Consumption by Region (2021-2026)
  4. 8.2.2 Global GLP-1 Drug Peptide API Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America GLP-1 Drug Peptide API Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe GLP-1 Drug Peptide API Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific GLP-1 Drug Peptide API Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America GLP-1 Drug Peptide API Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa GLP-1 Drug Peptide API Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 GLP-1 Drug Peptide API Value Chain Analysis
  2. 9.1.1 GLP-1 Drug Peptide API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GLP-1 Drug Peptide API Production Mode & Process
  6. 9.2 GLP-1 Drug Peptide API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GLP-1 Drug Peptide API Distributors
  9. 9.2.3 GLP-1 Drug Peptide API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst